Rain Enhancement Technologies Ownership | Who Owns Rain Enhancement Technologies?
Rain Enhancement Technologies Ownership Summary
Rain Enhancement Technologies is owned by 8.21% institutional investors, 73.61% insiders, and 18.17% retail investors. Ubs group is the largest institutional shareholder, holding 0.46% of RAIN shares. Loncar China BioPharma ETF is the top mutual fund, with 0.17% of its assets in Rain Enhancement Technologies shares.
RAIN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rain Enhancement Technologies | 8.21% | 73.61% | 18.17% |
| Sector | Utilities Stocks | 34.92% | 8.47% | 56.60% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ubs group | 34.51K | 0.46% | $87.66K |
| Vanguard fiduciary trust | 17.16K | 0.23% | $43.58K |
| Sbi securities | 3.00 | - | $8.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ubs group | 34.51K | - | $87.66K |
| Sbi securities | 3.00 | - | $8.00 |
| Vanguard fiduciary trust | 17.16K | - | $43.58K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard fiduciary trust | 17.16K | - | 17.16K |
| Sbi securities | 3.00 | - | 3.00 |
| Ubs group | 34.51K | - | -595.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 34.51K | - | -595.00 |
| Sbi securities | 3.00 | - | 3.00 |
| Vanguard fiduciary trust | 17.16K | - | 17.16K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 17.16K | - | 17.16K | $43.58K |
| Sbi securities | 3.00 | - | 3.00 | $8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 13 | -13.33% | 618,367 | -14.52% | 8 | 8.90% | 5 | -54.55% | 5 | 400.00% |
| Sep 30, 2025 | 15 | 66.67% | 723,381 | 12.12% | 9 | 13.29% | 11 | 83.33% | 1 | - |
| Jun 30, 2025 | 9 | 12.50% | 645,164 | 7.57% | 8 | 12.34% | 6 | -25.00% | 1 | - |
| Mar 31, 2025 | 8 | - | 599,762 | - | 8 | - | 8 | - | - | - |
| Dec 31, 2023 | 59 | - | 16,868,950 | 4.38% | 46 | 2.35% | 33 | 50.00% | 11 | -42.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Loncar China BioPharma ETF | 61.84K | 0.17% | - |
| BlackRock Extended Mkt Composite | 41.68K | 0.11% | 297.00 |
| NT R2000 Growth Index Fund - NL | 30.17K | 0.08% | 30.17K |
| Russell Inv Tax-Managed US Mid&Sm Cap S | 23.15K | 0.06% | - |
| NT R2000 Value Index Fund - NL | 12.37K | 0.03% | -7.42K |
| SSgA U.S. Extended Market Index Class I | 3.10K | 0.01% | - |
| Blackstone Alternative Multi-Strategy I | 3.00K | 0.01% | -200.00 |
| NT R3000 Index Fund - NL | 1.67K | 0.00% | 885.00 |
| NT US Market Cap Idx Fd - L | 1.32K | 0.00% | - |
| SSgA U.S. Total Market Index Strategy | 894.00 | 0.00% | -21.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 09, 2025 | DICKERSON LYMAN B | - | Sell | $10.05K |
| Sep 11, 2025 | DICKERSON LYMAN B | - | Sell | $2.31K |
| Sep 12, 2025 | DICKERSON LYMAN B | - | Sell | $27.67K |
| Sep 10, 2025 | DICKERSON LYMAN B | - | Sell | $1.19K |
| Dec 14, 2023 | TANG KEVIN C | - | Sell | $29.53K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q1 | - | - |
| 2023 Q4 | 5 | 3 |
| 2023 Q3 | - | - |
| 2023 Q2 | 9 | 1 |
| 2023 Q1 | - | - |
RAIN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools